Pay in installments of $5.04 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
GLP 1 Medications and Birth Control Pills How Do They Interact? Buy Retatrutide 20mg High Purity Triple Agonist Peptide for Research Could Ozempic Slow Aging? A New Clinical Trial Analysis Opens The Door What Are the Key Findings on Retatrutide for Managing Obesity and Meta Prime Lab Peptides How GLP 1 Drugs Affect Your Mouth The Doc Rok
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 17 reviews
Sort
Product Reviews
★★★★★ 5
Good protection, easy to tell where it was applied
Size: 2.5 Fl Oz (Pack of 1)
Putting sunscreen on kids can be a struggle. This product does many things well: easy to put on, no stinging eyes or coughing like there is with spray, provides good coverage, lasts a long time while sweating, and blocks sun well. But the really cool part is it goes on blue initially (dries clear/slightly white). This is helpful when my little one puts on his own sunscreen because it makes it easier to see the spots he missed (usually many) and helps ensure he fills in the gaps.
Also great for the adults - I used it on vacation when I ran out of mine and it worked very well (great if you have arm hair too - not as sticky as many others)
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 1, 2023
★★★★★ 4
Nice sunscreen, not very blue
Size: 2.5 Fl Oz (Pack of 1)
Rolls on/spreads very nicely. Not too sticky and my toddler doesn’t mind it the way she does most other sunscreens. Seems to protect well. It’s fun “blue” color is extremely faint and the product itself is closer to cloud white than sky blue. I would imagine it would barely show up at all on darker skin tones but still not complaining as she is letting me apply it despite the absence of the ‘finger painting’ I had tried to get her excited for.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 27, 2025
★★★★★ 5
Summer must have
Size: 2.5 Fl Oz (Pack of 1)
My family and I travelled to the beach this past summer. I have 2 very active kiddos and this roll on sunscreen was so helpful! It goes on quickly and has great protection.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 2, 2025
★★★★★ 5
Great sunscreen
Size: 2.5 Fl Oz (Pack of 1)
Fantastic. My kids love this product. I love that I can see where I applied, and then the blue tint completely disappears after rubbing it in. I just hope it doesn’t have some weird chemicals to accomplish this effect. It also doesn’t seem to burn their eyes.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 4, 2026
★★★★★ 3
Face sun screen
Size: 2.5 Fl Oz (Pack of 1)
This works well as far as UV protection although it does not rub in very well. It leaves your face white.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 1, 2026
recommand products
GLP-1 Receptor Agonist Market Size
26.65
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
27.17
India GLP-1 Receptor Agonist Market Report, Pharma Drug Market Size, Market revenue, Major companies, Market sales, demand
22.03
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
27.54
Nephroprotective effects of GLP-1 receptor agonists: where do we stand? | Journal of Nephrology
27.58